Identification of SNPs, mapping and analysis of allele frequencies in two candidate genes for meat production traits: the porcine myosin heavy chain 2B (MYH4 ) and the skeletal muscle myosin regulatory light chain 2 (HUMMLC2B )

2003 ◽  
Vol 34 (3) ◽  
pp. 221-225 ◽  
Author(s):  
R. Davoli ◽  
L. Fontanesi ◽  
M. Cagnazzo ◽  
E. Scotti ◽  
L. Buttazzoni ◽  
...  
2004 ◽  
Vol 96 (4) ◽  
pp. e103-e110 ◽  
Author(s):  
Youri E.C. Taes ◽  
Marijn Speeckaert ◽  
Evelien Bauwens ◽  
Marc R. De Buyzere ◽  
Johan Libbrecht ◽  
...  

2016 ◽  
Vol 37 (1-2) ◽  
pp. 1-5 ◽  
Author(s):  
Kevin A. Murach ◽  
James R. Bagley ◽  
Kathryn A. McLeland ◽  
Jose A. Arevalo ◽  
Anthony B. Ciccone ◽  
...  

2002 ◽  
Vol 87 (2) ◽  
pp. 182-186 ◽  
Author(s):  
Espen Spangenburg ◽  
Robert Talmadge ◽  
Timothy Musch ◽  
Pfeifer P. ◽  
Richard McAllister ◽  
...  

2000 ◽  
Vol 279 (3) ◽  
pp. R1076-R1081 ◽  
Author(s):  
P. Rajab ◽  
J. Fox ◽  
S. Riaz ◽  
D. Tomlinson ◽  
D. Ball ◽  
...  

Prolonged treatment with the β2-adrenoceptor agonist clenbuterol (1–2 mg · kg body mass−1 · day −1) is known to induce the hypertrophy of fast-contracting fibers and the conversion of slow- to fast-contracting fibers. We investigated the effects of administering a lower dose of clenbuterol (250 μg · kg body mass−1 · day−1) on skeletal muscle myosin heavy chain (MyHC) protein isoform content and adenine nucleotide (ATP, ADP, and AMP) concentrations. Male Wistar rats were administered clenbuterol ( n = 8) or saline ( n = 6) subcutaneously for 8 wk, after which the extensor digitorum longus (EDL) and soleus muscles were removed. We demonstrated an increase of type IIa MyHC protein content in the soleus from ∼0.5% in controls to ∼18% after clenbuterol treatment ( P < 0.05), which was accompanied by an increase in the total adenine nucleotide pool (TAN; ∼19%, P < 0.05) and energy charge [E-C = (ATP + 0.5 ADP)/(ATP + ADP + AMP); ∼4%; P < 0.05]. In the EDL, a reduction in the content of the less prevalent type I MyHC protein from ∼3% in controls to 0% after clenbuterol treatment ( P < 0.05) occurred without any alterations in TAN and E-C. These findings demonstrate that the phenotypic changes previously observed in slow muscle after clenbuterol administration at 1–2 mg · kg body mass−1 · day−1 are also observed at a substantially lower dose and are paralleled by concomitant changes in cellular energy metabolism.


Sign in / Sign up

Export Citation Format

Share Document